Macrophage inflammatory protein 1α enhances in a different manner adhesion of hematopoietic progenitor cells from bone marrow, cord blood, and mobilized peripheral blood

Experimental Hematology

Volumn 27, Issue 11, 1999, Pages 1637-1645

  Suehiro, Youko ^a   Muta, Koichiro ^a   Umemura, Tsukuru ^c   Abe, Yasunobu ^a   Nishimura, Junji ^b   Nawata, Hajime ^a  

^a Department of Medical Technology   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c Med Inst Bioregulation Kyushu U ^*

Author keywords

Adhesion; Hematopoietic progenitor cells; Integrin; Macrophage inflammatory protein 1

Indexed keywords

CD34 ANTIGEN; F ACTIN; FIBRONECTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; STEM CELL FACTOR;

ACTIN POLYMERIZATION; ARTICLE; BLOOD CELL; BONE MARROW CELL; CELL ADHESION; CELL MATURATION; CELL MIGRATION; COLONY FORMING CELL; CYTOSKELETON; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LYMPHOCYTE HOMING; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

ACTINS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD34; BIOPOLYMERS; BONE MARROW CELLS; CELL ADHESION; CELL MOVEMENT; COLONY-FORMING UNITS ASSAY; CYTOSKELETON; FETAL BLOOD; FIBRONECTINS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; TISSUE DONORS;

EID: 0032697408     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00103-4     Document Type: Article

References (38)

1. Gordon M.Y. Extracelular matrix of the bone marrow microenvironment. Br J Haematol. 70:1988;1.
2. Dexter TM, Allen TD, Lajtha LG (197) Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 91:335.
3. Verfaillie C.M. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood. 82:1993;2045.
4. Coulombel L., Auffray I., Gaugler M.H., Rosemblatt M. Expression and function of integrins on hematopoietic progenitor cells. Acta Haematol. 97:1997;13.
5. Simmons P.J., Levesque J.-P., Zannettino A.C.W. Adhesion molecules in haemopoiesis. Bailliére's Clin Haematol. 10:1997;485.
6. Verfaillie C.M., McCarthy J.B., McGlave P.B. Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin. J Exp Med. 174:1991;693.
7. Kerst J.M., Sanders J.B., Slaper-Cortenbach I.C.M., Doorakkers M.C., Hooibrink B., van Oers R.H.J., von dem Borne A.E.G.K., van der Schoot C.E. α4β1 and α5β1 are differentially expressed during myelopoiesis and mediate the adherence of human CD34+ cells to fibronectin in an activation-dependent way. Blood. 81:1993;344.
8. Williams D.A., Rios M., Stephens C., Patel V.P. Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature. 352:1991;438.
9. Papayannopoulou T., Craddock C., Nakamoto B., Priestly G.V., Wolf N.S. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci U S A. 92:1995;9647.
10. Hirsch E., Iglesias A., Potocnik A.J., Hartmann U., Fässler R. Impaired migration but not differentiation of haematopoietic stem cells in the absence of β1 integrins. Nature. 380:1996;171.
11. Hynes R.O. Integrins. versatility, modulation, and signaling in cell adhesion Cell. 69:1992;11.
12. Juliano R.L., Haskill S. Signal transduction from the extracellular matrix. J Cell Biol. 120:1993;577.
13. Kovach N.L., Lin N., Yednock T., Harlan J.M., Broudy V.C. Stem cell factor modulates avidity of α4β1 and α5β1 integrins expressed on hematopoietic cell lines. Blood. 85:1995;159.
14. Lévesque J.-P., Haylock D.N., Simmons P.J. Cytokine regulation of proliferation and cell adhesion are correlated events in human CD34+ hemopoietic progenitors. Blood. 88:1996;1168.
15. Nakao M., Nomiyama H., Shimada K. Structures of human genes coding for cytokine LD78 and their expression. Mol Cell Biol. 10:1990;3646.
16. Rot A., Krieger M., Brunner T., Bischoff S.C., Schall T.J., Dahinden C.A. RANTES and macrophage inflammatory protein 1α induce the migration and activation of normal human eosinophil granulocytes. J Exp Med. 176:1992;1489.
17. Taub D.D., Conlon K., Lloyd A.R., Oppenheim J.J., Kelvin Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1α and MIP-1β Science. 260:1993;355.
18. Alam R., Forsythe P.A., Stafford S., Lett-Brown M.A., Grant J.A. Macrophage inflammatory protein-1α activates basophils and mast cells. J Exp Med. 176:1992;781.
19. Wolpe S.D., Cerami A. Macrophage inflammatory proteins 1 and 2. members of a novel superfamily of cytokines FASEB J. 3:1989;2565.
20. Oppenheim J.J., Zachariae C.O.C., Mukaida N., Matsushima K. Properties of the novel proinflammatory supergene "inter crine" cytokine family. Annu Rev Immunol. 9:1991;617.
21. Schall T.J., Bacon K., Camp R.D.R., Kaspari J.W., Goeddel D.V. Human macrophage inflammatory protein α (MIP-1α) and MIP-1β chemokines attract distinct populations of lymphocytes. J Exp Med. 177:1993;1821.
22. Cook D.N., Beck M.A., Coffman T.M., Kirby S.L., Sheridan J.F., Pragnell I.B., Smithies O. Requirement of MIP-1α for an inflammatory response to viral infection. Science. 269:1995;1583.
23. Graham G.J., Wright E.G., Hewick R., Wolpe S.D., Wilkie N.M., Donaldson D., Lorimore S., Pragnell I.B. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature. 344:1990;442.
24. Broxymeyer H.E., Sherry B., Lu L., Cooper S., Oh K.-O., Tekamp-Olson P., Kwon B.S., Cerami A. Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood. 76:1990;1110.
25. Maze R., Sherry B., Kwon B.S., Cerami A., Broxmeyer H.E. Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1α J Immunol. 149:1992;1004.
26. Plumb M., Graham G.J., Grove M., Reid A., Pragnell I.B. Molecular aspects of a negative regulator of hematopoiesis. Br J Cancer. 64:1991;990.
27. Su S.B., Mukaida N., Wang J.B., Zhang Y., Takami A., Nakao S., Matsushima K. Inhibition of immature erythroid progenitor cell proliferation by macrophage inflammatory protein-1α by interacting mainly with a C-C chemokine receptor, CCR1. Blood. 90:1997;605.
28. Lévesque J.-P., Leavesley D.I., Niutta S., Vadas M., Simmons P.J. Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med. 181:1995;1805.
29. Schofield K.P., Rushton G., Humphries M.J., Dexter T.M., Gallagher J.T. Influence of interleukin-3 and other growth factors on α4β1 integrin-mediated adhesion and migration of human hematopoietic progenitor cells. Blood. 90:1997;1858.
30. Tanaka Y., Adams D.H., Hubscher S., Hirano H., Siebenlist U., Shaw S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β Nature. 361:1993;79.
31. Butcher E.C. Leukocyte-endothelial cell recognition. three (or more) steps to specificity and diversity Cell. 67:1991;1033.
32. Campbell J.J., Qin S., Bacon K.B., Mackay C.R., Butcher E.C. Biology of chemokine and classical chemoattractant receptors. differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells J Cell Biol. 134:1996;255.
33. Bokoch G.M. Chemoattractant signaling and leukocyte activation. Blood. 86:1995;1649.
34. Verfaillie C.M., Catanzarro P.M., Li W.N. Macrophage inflammatory protein 1α, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro. J Exp Med. 179:1994;643.
35. Dunlop D.J., Wright E.G., Lorimore S., Graham G.J., Holyoake T., Kerr D.J., Wolpe S.D., Pragnell I.B. Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP 1α in vivo. Blood. 79:1992;2221.
36. Lord B.I., Dexter T.M., Clements J.M., Hunter M.A., Gearing A.J.H. Macrophage inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo. Blood. 79:1992;2605.
37. Broxmeyer H.E., Orazi A., Hague N.L., Sledge G.W. Jr., Rasmussen H., Gordon M.S. Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1α, in a phase I clinical trial in patients with relapsed/refractory breast cancer. Blood Cell Mol Dis. 24:1998;14.
38. Yamaguchi M., Ikebuchi K., Hirayama F., Sato N., Mogi Y., Ohkawara J., Yoshikawa Y., Sawada K., Koike T., Sekiguchi S. Different adhesive characteristics and VLA-4 expression of CD34+ progenitors in G0/G1 versus S+G2/M phases of the cell cycle. Blood. 92:1998;842.